Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular onchocerciasis.

B Thylefors

    Bulletin of the World Health Organization
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Onchocerciasis, a parasitic infection affecting over 20 million people, causes significant blindness, particularly in Africa and Latin America. Improved treatment and prevention strategies are crucial to avoid vision loss.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control.

    Global public health·2009
    Same author

    The Mectizan Donation Program (MDP).

    Annals of tropical medicine and parasitology·2008
    Same author

    Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.

    Tropical medicine & international health : TM & IH·2008
    Same author

    A global initiative for the elimination of avoidable blindness.

    Community eye health·2007
    Same author

    Towards the elimination of onchocerciasis.

    Annals of tropical medicine and parasitology·2007
    Same author

    Eliminating onchocerciasis as a public health problem.

    Tropical medicine & international health : TM & IH·2004
    Same journal

    Diplomatic roles of regional coordinators for WHO Member States.

    Bulletin of the World Health Organization·2026
    Same journal

    Evaluation of an application for investments in cataract surgery, Ethiopia.

    Bulletin of the World Health Organization·2026
    Same journal

    An umbrella protocol for the clinical evaluation of diagnostics in infectious disease.

    Bulletin of the World Health Organization·2026
    Same journal

    Fundamental changes in regulation to improve access to biosimilars.

    Bulletin of the World Health Organization·2026
    Same journal

    A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

    Bulletin of the World Health Organization·2026
    Same journal

    Ebola at a critical juncture: preparedness must outpace transmission.

    Bulletin of the World Health Organization·2026
    See all related articles

    Area of Science:

    • Medical Parasitology
    • Ophthalmology
    • Tropical Medicine

    Background:

    • Onchocerciasis, caused by Onchocerca volvulus, infects over 20 million people globally.
    • It is a leading cause of blindness in parts of Africa and Latin America, affecting an estimated 200,000-500,000 individuals.
    • Current treatments for onchocerciasis are challenging and can cause severe adverse reactions.

    Purpose of the Study:

    • To highlight the significant public health burden of onchocerciasis, emphasizing its impact on vision.
    • To review current treatment modalities and their limitations.
    • To underscore the need for improved prevention and treatment strategies, including vector control and novel therapeutic agents.

    Main Methods:

    • Review of existing literature on onchocerciasis epidemiology, clinical manifestations, and treatment outcomes.

    Related Experiment Videos

  • Analysis of the challenges associated with current therapeutic regimens.
  • Evaluation of the feasibility and cost-effectiveness of vector control methods.

    • Main Results:

    • The combined use of diethylcarbamazine citrate and suramin remains the most suitable treatment option despite potential adverse reactions.
    • Early screening and treatment of high-risk individuals are essential to prevent ocular complications.
    • Vector control is effective but costly and requires long-term commitment.

    Conclusions:

    • Effective management of onchocerciasis requires a multi-faceted approach including early detection, appropriate treatment, and robust vector control.
    • Further research is imperative to develop safer and more effective treatments, chemoprophylactic agents, and vaccines.
    • Preventing blindness from onchocerciasis necessitates sustained efforts in both treatment and transmission reduction.